(1)
Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients With COVID -19. Journal of Pharmaceutical Negative Results 2022, 13 (2), 82-86.